D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 75 Citations 15,592 301 World Ranking 1269 National Ranking 109
Medicine D-index 75 Citations 15,862 323 World Ranking 14778 National Ranking 1354

Overview

What is he best known for?

The fields of study he is best known for:

  • Immune system
  • Internal medicine
  • Gene

His primary areas of investigation include Immunology, Autoimmunity, T cell, Type 1 diabetes and Immune system. His Immunology study often links to related topics such as Islet. Mark Peakman combines subjects such as Autoimmune disease and Innate immune system with his study of Autoimmunity.

His studies deal with areas such as Acquired immune system, CD8, Microbiology, Human leukocyte antigen and Major histocompatibility complex as well as T cell. His study looks at the relationship between CD8 and fields such as T-cell receptor, as well as how they intersect with chemical problems. Mark Peakman works mostly in the field of Type 1 diabetes, limiting it down to concerns involving Immunotherapy and, occasionally, Proinsulin, Cytotoxic T cell and Antigen specific.

His most cited work include:

  • Defective Suppressor Function in CD4+CD25+ T-Cells From Patients With Type 1 Diabetes (683 citations)
  • Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health (418 citations)
  • CTLs are targeted to kill β cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope (307 citations)

What are the main themes of his work throughout his whole career to date?

Mark Peakman spends much of his time researching Immunology, Type 1 diabetes, Immune system, T cell and Diabetes mellitus. In his study, which falls under the umbrella issue of Immunology, Transplantation is strongly linked to Islet. The study incorporates disciplines such as Clinical trial, Bioinformatics, Proinsulin, Intensive care medicine and Disease in addition to Type 1 diabetes.

His T cell research is multidisciplinary, incorporating perspectives in MHC class I, CD8, Major histocompatibility complex and Cell biology. His studies in CD8 integrate themes in fields like Cytotoxic T cell, IL-2 receptor and T lymphocyte. The Diabetes mellitus study combines topics in areas such as Autoantibody and Internal medicine.

He most often published in these fields:

  • Immunology (72.03%)
  • Type 1 diabetes (40.11%)
  • Immune system (25.86%)

What were the highlights of his more recent work (between 2014-2021)?

  • Type 1 diabetes (40.11%)
  • Immunology (72.03%)
  • T cell (25.59%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Type 1 diabetes, Immunology, T cell, Autoimmunity and Immune system. His Type 1 diabetes research incorporates themes from Intensive care medicine, Internal medicine, Disease and Immunotherapy. The concepts of his Immunology study are interwoven with issues in Phenotype, Cytotoxic T cell and Islet.

His T cell study combines topics from a wide range of disciplines, such as Epitope, Computational biology, Major histocompatibility complex and Abatacept. His study focuses on the intersection of Autoimmunity and fields such as Vaccination with connections in the field of Glutamate decarboxylase and Adverse effect. Immune system and Human leukocyte antigen are frequently intertwined in his study.

Between 2014 and 2021, his most popular works were:

  • Abnormal neutrophil signature in the blood and pancreas of presymptomatic and symptomatic type 1 diabetes (114 citations)
  • Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes (106 citations)
  • Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes (106 citations)

In his most recent research, the most cited papers focused on:

  • Immune system
  • Gene
  • Internal medicine

Type 1 diabetes, Disease, Immunology, Autoimmunity and T cell are his primary areas of study. Mark Peakman combines subjects such as Cytotoxic T cell, Immune tolerance and Immunotherapy with his study of Type 1 diabetes. He interconnects Precision medicine, Clinical trial, Myeloid, Immune system and Intensive care medicine in the investigation of issues within Disease.

His Immunology study integrates concerns from other disciplines, such as Phenotype and Young adult. His study in Autoimmunity is interdisciplinary in nature, drawing from both Acquired immune system, Autoimmune disease, Adverse effect, Influenza A virus and Vaccination. His studies deal with areas such as Staining and Antigen as well as T cell.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Defective Suppressor Function in CD4+CD25+ T-Cells From Patients With Type 1 Diabetes

Shelley Lindley;Colin M. Dayan;Amanda Bishop;Bart O. Roep.
Diabetes (2005)

1059 Citations

Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health

Sefina Arif;Timothy I. Tree;Thomas P. Astill;Jennifer M. Tremble.
Journal of Clinical Investigation (2004)

559 Citations

CTLs are targeted to kill β cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope

Ania Skowera;Richard J. Ellis;Ruben Varela-Calviño;Sefina Arif.
Journal of Clinical Investigation (2008)

407 Citations

A Single Autoimmune T Cell Receptor Recognizes More Than a Million Different Peptides

Linda Wooldridge;Julia Ekeruche-Makinde;Hugo A. van den Berg;Anna Skowera;Anna Skowera.
Journal of Biological Chemistry (2012)

391 Citations

Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM

M. J. Hussain;M. Peakman;H. Gallati;S. S. S. Lo.
Diabetologia (1996)

291 Citations

Translational mini-review series on type 1 diabetes: Systematic analysis of T cell epitopes in autoimmune diabetes.

T. P. Di Lorenzo;M. Peakman;B. O. Roep.
Clinical and Experimental Immunology (2007)

289 Citations

Resident CD141 (BDCA3)+ dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation

Chung-Ching Chu;Niwa Ali;Panagiotis Karagiannis;Paola Di Meglio.
Journal of Experimental Medicine (2012)

279 Citations

Antigen Targets of Type 1 Diabetes Autoimmunity

Bart O Roep;Mark Peakman.
Cold Spring Harbor Perspectives in Medicine (2012)

257 Citations

Peripheral and Islet Interleukin-17 Pathway Activation Characterizes Human Autoimmune Diabetes and Promotes Cytokine-Mediated β-Cell Death

Sefina Arif;Fabrice Moore;Katherine Marks;Thomas Bouckenooghe.
Diabetes (2011)

228 Citations

Type 1 Diabetes-Associated IL2RA Variation Lowers IL-2 Signaling and Contributes to Diminished CD4+CD25+ Regulatory T Cell Function

Garima Garg;Jennifer R Tyler;Jennie H M Yang;Antony J Cutler.
Journal of Immunology (2012)

214 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Mark Peakman

Bart O. Roep

Bart O. Roep

Leiden University Medical Center

Publications: 106

Matthias von Herrath

Matthias von Herrath

La Jolla Institute For Allergy & Immunology

Publications: 73

Carla J. Greenbaum

Carla J. Greenbaum

Virginia Mason Medical Center

Publications: 71

Mark A. Atkinson

Mark A. Atkinson

University of Florida

Publications: 67

Jamie Rossjohn

Jamie Rossjohn

Monash University

Publications: 58

Andrew K. Sewell

Andrew K. Sewell

Cardiff University

Publications: 57

Diego Vergani

Diego Vergani

King's College London

Publications: 55

Åke Lernmark

Åke Lernmark

Lund University

Publications: 54

Ezio Bonifacio

Ezio Bonifacio

TU Dresden

Publications: 48

John J. Miles

John J. Miles

James Cook University

Publications: 48

Kevan C. Herold

Kevan C. Herold

Yale University

Publications: 47

John A. Todd

John A. Todd

University of Oxford

Publications: 45

David Price

David Price

University of Aberdeen

Publications: 45

Jorma Ilonen

Jorma Ilonen

University of Turku

Publications: 43

Gerald T. Nepom

Gerald T. Nepom

Virginia Mason Medical Center

Publications: 42

Giorgina Mieli-Vergani

Giorgina Mieli-Vergani

King's College London

Publications: 42

Trending Scientists

Pascal Poupart

Pascal Poupart

University of Waterloo

Kobbi Nissim

Kobbi Nissim

Georgetown University

Bo Egardt

Bo Egardt

Chalmers University of Technology

Fumitoshi Kakiuchi

Fumitoshi Kakiuchi

Keio University

Ute Kaiser

Ute Kaiser

University of Ulm

Luzmila Arroyo

Luzmila Arroyo

Gabriel René Moreno Autonomous University

Tony J. Pitcher

Tony J. Pitcher

University of British Columbia

Edwin L. Fiscus

Edwin L. Fiscus

North Carolina State University

Hanjoong Jo

Hanjoong Jo

Georgia Institute of Technology

Jean Prenen

Jean Prenen

KU Leuven

Stephen R. Noble

Stephen R. Noble

British Geological Survey

Xiangzheng Deng

Xiangzheng Deng

Chinese Academy of Sciences

K. R. Chan

K. R. Chan

Ames Research Center

Michèle M.M. Mazzocco

Michèle M.M. Mazzocco

University of Minnesota

Nan Lin

Nan Lin

Harvard University

Robert A. Hiatt

Robert A. Hiatt

University of California, San Francisco

Something went wrong. Please try again later.